Results 121 to 130 of about 53,349 (300)

Effect of Oral Zinc Sulphate in Preventionof Radiation Induced OropharyngealMucositis During and After Radiotherapyin Patients with Head and Neck Cancers

open access: yesMiddle East Journal of Cancer, 2010
Introduction:Mucositis is a disturbing side effect of radiotherapy treatment forhead and neck cancer. To date, no effective modality for its prophylaxis and treatmenthas been found. We performed this study to evaluate the efficacy of oral zincsulphate in
Mohammad Mohammadianpanah   +7 more
doaj  

Cancer pain: current practice and emerging targets

open access: yesBritish Journal of Pharmacology, EarlyView.
Cancer pain (CP) arises from a complex interplay between the tumour and its microenvironment. Many patients experience a mixed pain phenotype that encompasses nociceptive, neuropathic and neuroinflammatory mechanisms, and vary across tumour type and disease stage. Despite decades of intensive research, the mainstay of cancer pain treatment is still non‐
Yi Ye   +5 more
wiley   +1 more source

Improved gut microbiota by selenium-enriched Bifidobacterium longum DD98 alleviates chemotherapy-induced intestinal mucositis via inhibiting the STING pathway

open access: yesnpj Science of Food
Intestinal mucositis, a common chemotherapy side effect, lacks effective treatments. This study evaluated the protective effect of selenium-enriched Bifidobacterium longum DD98 (SeDD98) on irinotecan-induced intestinal mucositis.
Yu-Shuang Qiu   +8 more
doaj   +1 more source

Alimentary mucositis: putting the guidelines into practice

open access: yes, 2006
The original publication can be found at www.springerlink.comBackground: The Mucositis Study Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology completed an evidence-based review of the ...
Keefe, D.   +3 more
core   +1 more source

Daraxonrasib and Beyond: Pan‐RAS Inhibition, Resistance, and Next‐Generation Strategies

open access: yesCancer Science, EarlyView.
ABSTRACT RAS proteins have long been considered difficult therapeutic targets, but allele‐selective inhibitors established the clinical tractability of mutant RAS. Daraxonrasib (RMC‐6236), an oral pan‐RAS inhibitor, has now extended this concept by targeting multiple mutant and wild‐type RAS proteins.
Ryo Honda
wiley   +1 more source

Efficacy of Episil® in patients with hematologic malignancies: a comparative study

open access: yesBMC Oral Health
Background Episil® is a nonabsorbable liquid medical material used to coat and protect the mucosa in patients with oral mucositis. A few studies have reported its efficacy in patients with head and neck cancer.
Taeko Fukutani   +7 more
doaj   +1 more source

Hepcidin promotes oral ulcer healing via amphiregulin production in rats

open access: yesJournal of Dental Sciences
Background/purpose: Hepcidin is an antimicrobial peptide that regulates iron metabolism. Recently, hepcidin was reported to promote wound healing. However, the mechanism underlying hepcidin signaling in the oral mucosa remains unclear.
Naoto Taguchi   +7 more
doaj   +1 more source

L‐VISP: LSTM Visualization for Interpretable Symptom Prediction in Patient Cohorts

open access: yesComputer Graphics Forum, EarlyView.
L‐VISP is a human‐machine solution that uses visual analytics for LSTM modelling in clinical research. L‐VISP uses custom visual encodings to make multiple LSTM variants interpretable, supporting a full range of analysis, from understanding model operations and evaluating performance to interpreting results in a clinical context.
C. Floricel   +6 more
wiley   +1 more source

Cancer treatment-induced oral mucositis [PDF]

open access: yes, 2007
Oral mucositis is one of the main complications in non-surgical cancer treatments. It represents the major dose-limiting toxicity for some chemotherapeutic agents, for radiotherapy of the head and neck region and for some radiochemotherapy combined ...
D. Alterio   +5 more
core   +1 more source

Randomized Controlled Clinical Trial Comparing Screw‐Retained Monolithic Zirconia Implant Crowns on Standardized Titanium Base Versus Customized Titanium Abutments– 3‐Years Data

open access: yesClinical Oral Implants Research, EarlyView.
ABSTRACT Objectives To assess 3‐year interim results of implant‐supported monolithic zirconia single crowns on standardized titanium base vs. customized titanium abutments. Material and Methods Patients in need of posterior implant were recruited.
Jenni Hjerppe   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy